Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

337 ARTÍCULOS , VIENDO DEL 1 AL 15

Systematic Review of the Costs and Benefits of Prescribed Cannabis-Based Medicines for the Management of Chronic Illness: Lessons from Multiple Sclerosis

Herzog S, Shanahan M, Grimison P, Tran A, Wong N, Lintzeris N, Simes J, Stockler M, Morton RL.

Pharmacoeconomics. 2018 Jan;36(1):67-78. doi: 10.1007/s40273-017-0565-6.

Advanced Symptom Management in Multiple Sclerosis

Crabtree-Hartman E.

Neurol Clin. 2018 Feb;36(1):197-218. doi: 10.1016/j.ncl.2017.08.015.

Plasma oxysterols: biomarkers for diagnosis and treatment in spastic paraplegia type 5

Marelli C, Lamari F, Rainteau D, Lafourcade A, Banneau G, Humbert L, Monin ML, Petit E, Debs R, Castelnovo G, Ollagnon E, Lavie J, Pilliod J, Coupry I, Babin PJ, Guissart C, Benyounes I, Ullmann U, Lesca G, Thauvin-Robinet C, Labauge P, Odent S, Ewenczyk C, Wolf C, Stevanin G, Hajage D, Durr A, Goizet C, Mochel F.

Brain. 2018 Jan 1;141(1):72-84. doi: 10.1093/brain/awx297.

RAB18 Deficiency

Handley M, Sheridan E.

2018 Jan 4. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.

Personalized upper limb training combined with anodal-tDCS for sensorimotor recovery in spastic hemiparesis: study protocol for a randomized controlled trial

Levin MF, Baniña MC, Frenkel-Toledo S, Berman S, Soroker N, Solomon JM, Liebermann DG.

Trials. 2018 Jan 4;19(1):7. doi: 10.1186/s13063-017-2377-6.

A systematic review: efficacy of botulinum toxin in walking and quality of life in post-stroke lower limb spasticity

Gupta AD, Chu WH, Howell S, Chakraborty S, Koblar S, Visvanathan R, Cameron I, Wilson D.

Syst Rev. 2018 Jan 5;7(1):1. doi: 10.1186/s13643-017-0670-9.

Demographics and clinical characteristics of primary lateral sclerosis: case series and a review of literature

Ramanathan RS, Rana S.

Neurodegener Dis Manag. 2018 Feb;8(1):17-23. doi: 10.2217/nmt-2017-0051. Epub 2018 Jan 10.

Innovative STRoke Interactive Virtual thErapy (STRIVE) online platform for community-dwelling stroke survivors: a randomised controlled trial protocol

Johnson L, Bird ML, Muthalib M, Teo WP.

BMJ Open. 2018 Jan 9;8(1):e018388. doi: 10.1136/bmjopen-2017-018388.

Analysis of a 15-years' experience in including shoulder muscles, when treating upper-limb spasticity post-stroke with botulinum toxin type A

Carvalho MP, Pinto D, Gorayeb M, Jacinto J.

Top Stroke Rehabil. 2018 Apr;25(3):194-202. doi: 10.1080/10749357.2017.1420009. Epub 2018 Jan 11.

The therapeutic effects of Cannabis and cannabinoids: An update from the National Academies of Sciences, Engineering and Medicine report

Abrams DI.

Eur J Intern Med. 2018 Mar;49:7-11. doi: 10.1016/j.ejim.2018.01.003. Epub 2018 Jan 9.

Intrathecal baclofen therapy versus conventional medical management for severe poststroke spasticity: results from a multicentre, randomised, controlled, open-label trial (SISTERS)

Creamer M, Cloud G, Kossmehl P, Yochelson M, Francisco GE, Ward AB, Wissel J, Zampolini M, Abouihia A, Berthuy N, Calabrese A, Loven M, Saltuari L.

J Neurol Neurosurg Psychiatry. 2018 Jun;89(6):642-650. doi: 10.1136/jnnp-2017-317021. Epub 2018 Jan 11.

OnabotulinumtoxinA for the Treatment of Poststroke Distal Lower Limb Spasticity: A Randomized Trial

Wein T, Esquenazi A, Jost WH, Ward AB, Pan G, Dimitrova R.

PM R. 2018 Jul;10(7):693-703. doi: 10.1016/j.pmrj.2017.12.006. Epub 2018 Jan 9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias